Medmay Introduces New DX-8 Series Auto Hematology Analyzer
The DX-8 Series system combines CBC+DIFF, CRP, SAA, and HbA1c testing in a single platform with throughput up to 100 tests per hour.
The DX-8 Series system combines CBC+DIFF, CRP, SAA, and HbA1c testing in a single platform with throughput up to 100 tests per hour.
BEACONS, a multi-state collaboration led by Mass General Brigham and Ariadne Labs, will enroll up to 30,000 newborns to explore adding genomic sequencing in US newborn screening.
Despite powerful advances in precision medicine, most doctors remain untrained in these emerging diagnostic tools.
The integration is designed to bridge specimen grossing with digital pathology workflows for improved diagnostic accuracy and efficiency.
Tulsa Medical Lab chooses PathFlow system to unify diagnostic processes across multiple laboratory information systems.
The ethyl alcohol assay categorization enables moderate complexity laboratories to expand drug screening capabilities on the Abbott analyzer platform.
The infrared dye antibody conjugates aim to expand human phenotyping experiments innovation and make high-parameter flow cytometry more accessible.
The DX-60 system offers 28 reportable parameters, malaria detection capabilities, and requires minimal sample volumes for testing.
Market growth driven by expanding clinical applications and regulatory innovation, with kits and reagents dominating product segments.
New instrument features StreamFocus ionization technology and AI-powered intelligence for enhanced sensitivity and efficiency in clinical laboratories.
Research-use-only assay identifies 28 urinary targets and 25 antibiotic resistance markers with same-day turnaround time.
The companies plan to create a fully automated PCR testing system for infectious disease diagnosis and treatment monitoring.
The CLIA-waived immunoassay delivers results in as fast as 10 minutes and is designed for physician offices, urgent care centers, and decentralized hospital labs.
The sharp increase in fentanyl in random drug checks suggests more workers are using the opioid after they have passed pre-employment screens.